| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Jaeb Center for Health Research, Tampa, Florida.
PURPOSE. To describe the health-related quality of life, measured with the National Eye Institute Visual Function Questionnaire (NEI–VFQ), of patients several years after the onset of optic neuritis, according to their neurologic and visual status; to assess the relationship between the NEI–VFQ subscales and clinical measures of visual function; and to assess the internal consistency reliability of the NEI–VFQ subscales.
METHODS. The NEI–VFQ was administered to 244 patients 5 to 8 years after treatment for an episode of acute optic neuritis as part of the Optic Neuritis Treatment Trial. Visual acuity, visual field, contrast sensitivity, and color vision were measured at the same time as questionnaire completion.
RESULTS. The NEI–VFQ scores generally were lower than those reported for a disease-free group. Reported dysfunction was greater when multiple sclerosis was present and when visual acuity was abnormal, supporting the construct validity of the NEI–VFQ. Rank correlations between the NEI–VFQ subscales and clinical measures of visual function were moderate at best. Internal consistency reliability was generally high for most of the NEI–VFQ subscales.
CONCLUSIONS. These findings add support to the use of the NEI–VFQ as a valuable measure of self-reported visual impairment.
This article has been cited by other articles:
|
|
 |
|
  T. E. Clemons, M. C. Gillies, E. Y. Chew, A. C. Bird, T. Peto, M. Figueroa, M. W. Harrington, and for the MacTel Research Group The National Eye Institute Visual Function Questionnaire in the Macular Telangiectasia (MacTel) Project Invest. Ophthalmol. Vis. Sci., October 1, 2008; 49(10): 4340 - 4346. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. J. Volpe The Optic Neuritis Treatment Trial: A Definitive Answer and Profound Impact With Unexpected Results Arch Ophthalmol, July 1, 2008; 126(7): 996 - 999. [Full Text] [PDF]
|
|
|
|
 |
|
 L. J. Balcer Clinical practice. Optic neuritis. N. Engl. J. Med., March 23, 2006; 354(12): 1273 - 1280. [Full Text] [PDF]
|
|
|
|
|
|
Submacular Surgery Trials Research Group Health- and Vision-Related Quality of Life Among Patients With Ocular Histoplasmosis or Idiopathic Choroidal Neovascularization at Enrollment in a Randomized Trial of Submacular Surgery: Submacular Surgery Trials Report No. 5 Arch Ophthalmol, January 1, 2005; 123(1): 78 - 88. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. A. Deramo, T. A. Cox, A. B. Syed, P. P. Lee, and S. Fekrat Vision-Related Quality of Life in People With Central Retinal Vein Occlusion Using the 25-Item National Eye Institute Visual Function Questionnaire Arch Ophthalmol, September 1, 2003; 121(9): 1297 - 1302. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
The Collaborative Ocular Melanoma Study-Quality of Development and Validation of Disease-Specific Measures for Choroidal Melanoma: COMS-QOLS Report No. 2 Arch Ophthalmol, July 1, 2003; 121(7): 1010 - 1020. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
The Submacular Surgery Trials Research Group Responsiveness of the National Eye Institute Visual Function Questionnaire to Changes in Visual Acuity: Findings in Patients With Subfoveal Choroidal Neovascularization--SST Report No. 1 Arch Ophthalmol, April 1, 2003; 121(4): 531 - 539. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M W Nortvedt and T Riise The use of quality of life measures in multiple sclerosis research Multiple Sclerosis, February 1, 2003; 9(1): 63 - 72. [Abstract] [PDF]
|
|
|
|
|
|
T. E. Clemons, E. Y. Chew, S. B. Bressler, W. McBee, and for the AREDS Research Group National Eye Institute Visual Function Questionnaire in the Age-Related Eye Disease Study (AREDS): AREDS Report No. 10 Arch Ophthalmol, February 1, 2003; 121(2): 211 - 217. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L J van Rijn, H Wilhelm, M Emesz, R Kaper, S Heine, S Nitsch, G Grabner, and H J Volker-Dieben Relation between perceived driving disability and scores of vision screening tests Br. J. Ophthalmol., November 1, 2002; 86(11): 1262 - 1264. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Klein, S. E. Moss, B. E. K. Klein, P. Gutierrez, and C. M. Mangione The NEI-VFQ-25 in People With Long-term Type 1 Diabetes Mellitus: The Wisconsin Epidemiologic Study of Diabetic Retinopathy Arch Ophthalmol, May 1, 2001; 119(5): 733 - 740. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. T. Broman, B. Munoz, S. K. West, J. Rodriguez, R. Sanchez, R. Snyder, and R. Klein Psychometric Properties of the 25-Item NEI-VFQ in a Hispanic Population: Proyecto VER Invest. Ophthalmol. Vis. Sci., March 1, 2001; 42(3): 606 - 613. [Abstract] [Full Text]
|
|
|
|
|
|
L. J Balcer, M. L Baier, A. M Kunkle, R. A Rudick, B. Weinstock-Guttman, N. Simonian, S. L Galetta, G. R Cutter, and M. G Maguire Self-reported visual dysfunction in multiple sclerosis: results from the 25-Item National Eye Institute Visual Function Questionnaire (VFQ-25) Multiple Sclerosis, December 1, 2000; 6(6): 382 - 385. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
